Melancholic and atypical depression as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression

Depression and Anxiety

Volumn 34, Issue 3, 2017, Pages 246-256

  Cuijpers, Pim ^a,b   Weitz, Erica ^a,b   Lamers, Femke ^b,c   Penninx, Brenda W ^b,c   Twisk, Jos ^b   DeRubeis, Robert J ^d   Dimidjian, Sona ^e   Dunlop, Boadie W ^f   Jarrett, Robin B ^g   Segal, Zindel V ^h   Hollon, Steven D ⁱ  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ VANDERBILT UNIVERSITY   (United States)

Author keywords

antidepressants; atypical depression; cognitive behavior therapy; melancholia; meta analysis

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO;

ADULT; ARTICLE; ATYPICAL DEPRESSION; COGNITIVE BEHAVIORAL THERAPY; DEPRESSION; DSM-IV; EFFECT SIZE; EVIDENCE BASED MEDICINE; HAMILTON DEPRESSION RATING SCALE; HUMAN; INTENTION TO TREAT ANALYSIS; INTERMETHOD COMPARISON; MELANCHOLIA; META ANALYSIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT INDICATION; COGNITIVE THERAPY; FEMALE; MALE; PROCEDURES; PSYCHOLOGY; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; TREATMENT OUTCOME;

EID: 85008254481     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22580     Document Type: Article

References (32)

1. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM5) (5th ed.). Washington DC: Author.
2. Baumeister, H., & Gordon, P. (2012). Meta-review of depressive subtyping models. Journal of Affective Disorders, 139, 126–140.
3. Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009). Introduction to meta-analysis. Chichester, UK: Wiley.
4. Bower, P., Kontopantelis, E., Sutton, A., Kendrick, T., Richards, D., & Gilbody, S.. Liu, E.T.H. (2013). Who should get low-intensity treatments for depression? An individual patient data meta-analysis. BMJ, 346, f540.
5. Brookes, S. T., Whitely, E., Egger, M., Smith, G. D., Mulheranc, P. A., & Peters, T. J. (2004). Subgroup analyses in randomized trials: Risks of subgroup-specific analyses; power and sample size for the interaction test. Journal of Clinical Epidemiology, 57, 229–236.
6. Brown, W. A. (2007). Treatment response in melancholia. Acta Psychiatrica Scandinavica, 433S, 125–129.
7. Cuijpers, P., Berking, M., Andersson, G., Quigley, L., Kleiboer, A., & Dobson, K. S. (2013b). A meta-analysis of cognitive behavior therapy for adult depression, alone and in comparison to other treatments. Canadian Journal of Psychiatry, 58, 376–385.
8. Cuijpers, P., Hollon, S. D., van Straten, A., Bockting, C., Berking, M., & Andersson, G. (2013a). Does cognitive behaviour therapy have an enduring effect that is superior to keeping patients on continuation pharmacotherapy? A meta-analysis. BMJ Open, 3, e002542. doi:10.1136/bmjopen-2012-002542
9. Cuijpers, P., Reynolds, C. F., Donker, T., Li, J., Andersson, G., & Beekman, A. (2012). Personalized treatment of adult depression: Medication, psychotherapy or both? A systematic review. Depression and Anxiety, 29, 855–864.
10. Cuijpers, P., Sijbrandij, M., Koole, S. L., Andersson, G., Beekman, A. T., & Reynolds, C. F. (2016). The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: A meta-analysis of direct comparisons. World Psychiatry, 12, 137–148.
11. Cuijpers, P., Turner, E. H., Mohr, D. C., Hofmann, S. G., Andersson, G., Berking, M., & Coyne, J. (2014a). Comparison of psychotherapies for adult depression to pill placebo control groups: A meta-analysis. Psychological Medicine, 44, 685–695.
12. Cuijpers, P., van Straten, A., Warmerdam, L., & Andersson, G. (2008). Psychological treatment of depression: A meta-analytic database of randomized studies. BMC Psychiatry, 8, 36. doi:10.1186/1471-244X-8-36.
13. Cuijpers, P., Weitz, E., Twisk, J., Kuehner, C., Cristea, I., & David, D.. Hollon, S.D. (2014b). Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: An “individual patient data” meta-analysis. Depression and Anxiety, 31, 941–951.
14. DeRubeis, R. J., Hollon, S. D., Amsterdam, J. D., Shelton, R. C., Young, P. R., & Salomon, R. M. et al. (2005). Cognitive therapy vs. medications in the treatment of moderate to severe depression. Archives of General Psychiatry, 62, 409–416.
15. Dimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, R. J., & Addis, M. E. et al. (2006). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology, 74, 658–670.
16. Donders, A., van der Heiden, G., Stijnen, T., & Moons, K. (2012). A gentle introduction to imputation of missing values. Journal of Clinical Epidemiology, 59, 1087–1091.
17. Dunlop, B. W., Kelley, M. E., Mletzko, T. C., Velasquez, C. M., Craighead, E., & Mayberg, H. S. (2012). Depression beliefs, treatment preference, and outcomes in a randomized trial for major depressive disorder. Journal of Psychiatric Research, 46, 375–381.
18. Duval, S., & Tweedie, R. (2000). Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56, 455–463.
19. Hedges, L. V., & Olkin, I. (1985). Statistical methods for meta-analysis. San Diego, CA: Academic Press.
20. Henkel, V., Mergl, R., Allgaier, A. K., Kohnen, R., Möller, H. J., & Hegerl, U. (2006). Treatment of depression with atypical features: A meta-analytic approach. Psychiatry Res, 141, 89–101.
21. Higgins, J. P. T., & Altman, D. G. (2008). Chapter 8: Assessing risk of bias in included studies. In J. P. T. Higgins & S. Green (Eds.), Cochrane handbook for systematic reviews of interventions. Version 5.0.1. Retrieved from http://www.cochranehandbook.org
22. Jarrett, R. B., Schaffer, M., McIntire, D., Witt-Browder, A., Kraft, D., & Risser, R. C. (1999). Treatment of atypical depression with cognitive therapy or phenelzine: A double-blind, placebo-controlled trial. Archives of General Psychiatry, 56, 431–437.
23. Lamers, F., Rhebergen, D., Merikangas, K. R., de Jonge, P., Beekman, A. T. F., & Penninx, B. W. J. H. (2012). Stability and transitions of depressive subtypes over a 2-year follow-up. Psychological Medicine, 42, 2083–2093.
24. Lamers, F., Vogelzangs, N., Merikangas, K. R., de Jonge, P., Beekman, A. T. F., & Penninx, B. W. J. H. (2013). Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Molecular Psychiatry, 18, 692–699.
25. Leventhal, A. M., & Rehm, L. P. (2005). The empirical status of melancholia: Implications for psychology. Clinical Psychology Review, 25, 25–44.
26. National Institute for Health and Clinical Excellence (NICE). (2009). Depression: The treatment and management of depression in adults. Holborn: Author.
27. Penninx, B. W., Milaneschi, Y., Lamers, F., & Vogelzangs, N. (2013). Understanding the somatic consequences of depression: Biological mechanisms and the role of depression symptom profile. BMC Medicine, 15, 129.
28. Riley, R., Lambert, P., & Abo-Zaid, G. (2010). Meta-analysis of individual participant data: Rationale, conduct, and reporting. BMJ, 340, c221.
29. Segal, Z. V., Kennedy, S., Gemar, M., Hood, K., Pedersen, R., & Buis, T. (2006). Cognitive reactivity to sad mood provocation and the prediction of depressive relapse. Archives of General Psychiatry, 63, 749–755.
30. Stewart, J. W., McGrath, P. J., Quitkin, F. M., & Klein, D. F. (2007). Atypical depression: Current status and relevance to melancholia. Acta Psychiatrica Scandinavica 115, (Suppl. 433), 58–71.
31. Thase, M. E. (2007). Recognition and diagnosis of atypical depression. Journal of Clinical Psychiatry, 68(Suppl. 8), 11–16.
32. Uher, R., Dernovsek, Z., Mors, O., Hauser, J., Souery, D., & Zobel, A.. Farmer, A. (2011). Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. Journal of Affective Disorders, 132, 112–120.